ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Name

This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Email

This field is for validation purposes and should be left unchanged.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

CONTACT

If you have any further questions, please contact us using the contact form.

Name

Email(Required)

Your message(Required)

Newsletter

Yes, I would like to receive the weekly european biotechnology magazine newsletter.

Data privacy(Required)

I agree to the privacy policy.

Phone

This field is for validation purposes and should be left unchanged.

LATEST NEWS

Lee Haines, photographer

New drug kills mosquitos by blood poisoning

MPI for Biochemistry - Ausserhofer

Researchers crack the code of protein degradation

pleiotrope - wikipedia.org

Augustine Therapeutics NV raises €78m in Series A...

ADVERTISEMENT

MAGAZINE

1 / 4

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

2 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

3 / 4

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

4 / 4

The Three R (Replacement, Reduction and Refinement) principles developed over 60 years ago provide a framework for more humane lab animal testing and, more importantly, less of it. A range of in-vitro … more ➔

SPONSORED PUBLICATION

1 / 2

Sino Biological

Sino Biological

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

High-Quality HIV Antigens for Cutting-Edge Solutions more ➔

2 / 2

New England Biolabs

The Bridge to your success

Customized Enzymes and Reagents from New England Biolabs more ➔

newsletter_link

© BIOCOM Interrelations GmbH

LinkedIn
Instagram

Contact
Imprint
Privacy policy